Sandbox GGC14

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 16: Line 16:
== Disease ==
== Disease ==
-
Defects in human a-Galactosidase gene can cause Fabry disease, a lysosomal storage disorder characterized by the buildup of a-galactosylated substrates in the tissues. It is an X-linked inherited disorder affecting 1 in every 40,000 males characterized by chronic pain, vascular degeneration, cardiac abnormalities, and other symptoms. The disease displays distinct phenotypes correlated with the amount of residual enzymatic activity: a severe form affecting multiple organ systems including the eyes, liver, kidney, and heart; and a milder phenotype with symptoms restricted to cardiac and/or renal abnormalities. The severe phenotype generally results from a complete loss of enzymatic activity in affected individuals, whereas patients with milder phenotypes typically show some residual enzyme activity. The data base of independent Fabry disease mutations now numbers in the hundreds, from thousands of patients. Most Fabry disease patients have a single point mutation in their GLA gene coding for a-GAL, and over 400 missense and nonsense mutations have been identified in different patients. Other lysosomal storage disorder include the inherited diseases Tay-Sachs, Sandhoff, and Gaucher diseases.
+
Defects in human a-Galactosidase gene can cause Fabry disease, a lysosomal storage disorder characterized by the buildup of a-galactosylated substrates in the tissues. It is an X-linked inherited disorder that affects 1 in 40,000 males. It is often characterized by chronic pain, vascular degeneration, cardiac abnormalities, as well as other symptoms. The disease can show different levels of severity correlated with the amount of residual enzymatic activity. Organs affected can include the eyes, liver, kidney, and heart. More severe forms generally results from a complete loss of enzymatic activity, while milder phenotypes typically show some enzyme activity. Most people suffering from Fabry disease have a single point mutation in the gene, and over 400 missense and nonsense mutations have been identified. Other lysosomal storage disorder include the inherited diseases Tay-Sachs, Sandhoff, and Gaucher diseases.
== Relevance ==
== Relevance ==

Revision as of 10:59, 23 April 2018

1T0O - a-Galactosidase from Trichoderma reesei and Complex with Galactose

Caption for this structure

Drag the structure with the mouse to rotate

References

  1. Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
  2. Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
  3. Guce AI, Clark NE, Salgado EN, Ivanen DR, Kulminskaya AA, Brumer H 3rd, Garman SC. Catalytic mechanism of human alpha-galactosidase. J Biol Chem. 2010 Feb 5;285(6):3625-32. Epub 2009 Nov 25. PMID:19940122 doi:10.1074/jbc.M109.060145
  4. Golubev AM, Nagem RA, Brandao Neto JR, Neustroev KN, Eneyskaya EV, Kulminskaya AA, Shabalin KA, Savel'ev AN, Polikarpov I. Crystal structure of alpha-galactosidase from Trichoderma reesei and its complex with galactose: implications for catalytic mechanism. J Mol Biol. 2004 May 28;339(2):413-22. PMID:15136043 doi:http://dx.doi.org/10.1016/j.jmb.2004.03.062
Personal tools